- Home
- CBUS vs ATHR Comparison
CBUS vs ATHR Comparison
Compare CBUS & ATHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- ATHR
- Stock Information
- Founded
- CBUS 2010
- ATHR 2003
- Country
- CBUS United States
- ATHR United States
- Employees
- CBUS N/A
- ATHR N/A
- Industry
- CBUS Agricultural Chemicals
- ATHR
- Sector
- CBUS Industrials
- ATHR
- Exchange
- CBUS Nasdaq
- ATHR NYSE
- Market Cap
- CBUS 65.3M
- ATHR 76.5M
- IPO Year
- CBUS 2017
- ATHR 2025
- Fundamental
- Price
- CBUS $1.60
- ATHR $8.85
- Analyst Decision
- CBUS Strong Buy
- ATHR
- Analyst Count
- CBUS 3
- ATHR 0
- Target Price
- CBUS $22.00
- ATHR N/A
- AVG Volume (30 Days)
- CBUS 247.8K
- ATHR 151.2K
- Earning Date
- CBUS 08-07-2025
- ATHR 08-22-2025
- Dividend Yield
- CBUS N/A
- ATHR N/A
- EPS Growth
- CBUS N/A
- ATHR N/A
- EPS
- CBUS N/A
- ATHR N/A
- Revenue
- CBUS $4,751,000.00
- ATHR $1,406,012.00
- Revenue This Year
- CBUS $31.23
- ATHR N/A
- Revenue Next Year
- CBUS $70.93
- ATHR N/A
- P/E Ratio
- CBUS N/A
- ATHR N/A
- Revenue Growth
- CBUS 104.78
- ATHR N/A
- 52 Week Low
- CBUS $1.38
- ATHR $4.63
- 52 Week High
- CBUS $10.76
- ATHR $19.69
- Technical
- Relative Strength Index (RSI)
- CBUS 45.72
- ATHR N/A
- Support Level
- CBUS $1.60
- ATHR N/A
- Resistance Level
- CBUS $1.81
- ATHR N/A
- Average True Range (ATR)
- CBUS 0.10
- ATHR 0.00
- MACD
- CBUS 0.02
- ATHR 0.00
- Stochastic Oscillator
- CBUS 27.59
- ATHR 0.00
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About ATHR AETHER HOLDINGS INC
Aether Holdings Inc is an emerging financial technology platform company that offers proprietary research analytics, data and tools for both institutional and retail equity traders through flagship platform, SentimenTrader.com. Its platform currently provides coverage of U.S. equity and option securities, evaluating the equities and options markets and conducting assessments through analysts and technology daily.